Indhira Miosotis
Pérez Medrano
Universidad de Sevilla
Sevilla, EspañaPublicacións en colaboración con investigadores/as de Universidad de Sevilla (2)
2024
-
Predictive factors for decompensating events in patients with cirrhosis with primary biliary cholangitis under different lines of therapy
Hepatology (Baltimore, Md.), Vol. 80, Núm. 4, pp. 791-806
-
Rituximab is a safe and effective alternative treatment for patients with autoimmune hepatitis: Results from the ColHai registry
Liver International, Vol. 44, Núm. 9, pp. 2303-2314